CLADRIBINE
Generic: CLADRIBINE
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
CLADRIBINEActive Substance
2004-04-22Original Approval
CLADRIBINE is FDA application ANDA076571, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
302 reports
2
DRUG INEFFECTIVE
216 reports
3
FEBRILE NEUTROPENIA
208 reports
4
PYREXIA
185 reports
5
NEUTROPENIA
150 reports
6
PANCYTOPENIA
150 reports
7
THROMBOCYTOPENIA
126 reports
8
PRODUCT USE IN UNAPPROVED INDICATION
121 reports
9
PNEUMONIA
105 reports
10
RASH MACULO-PAPULAR
94 reports